The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
TOR-Mediated Cell-Cycle Activation Causes Neurodegeneration in a Drosophila Tauopathy Model
Open accessAbstract
Background Previous studies have demonstrated reexpression of cell-cycle markers within postmitotic neurons in neurodegenerative tauopathies, including Alzheimer's disease (AD). However, the critical questions of whether cell-cycle activation is causal or epiphenomenal to tau-induced neurodegeneration and which signaling pathways mediate cell-cycle activation in tauopathy remain unresolved. Results Cell-cycle activation accompanies wild-type and mutant tau-induced neurodegeneration in Drosophila, and genetically interfering with cell-cycle progression substantially reduces neurodegeneration. Our data support a role for cell-cycle activation downstream of tau phosphorylation, directly preceding apoptosis. We accordingly show that ectopic cell-cycle activation leads to apoptosis of postmitotic neurons in vivo. As in AD, TOR (target of rapamycin kinase) activity is increased in our model and is required for neurodegeneration. TOR activation enhances tau-induced neurodegeneration in a cell cycle-dependent manner and, when ectopically activated, drives cell-cycle activation and apoptosis in postmitotic neurons. Conclusions TOR-mediated cell-cycle activation causes neurodegeneration in a Drosophila tauopathy model, identifying TOR and the cell cycle as potential therapeutic targets in tauopathies and AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Pan-neuronal transgenic expression of an FTDP-17 mutant form of human tau, tauR406W, in Drosophila causes progressive neurodegeneration and provides a well-characterized in vivo genetic model of tau neurotoxicity7,15,16.”
From Tau promotes neurodegeneration through global chromatin relaxation (2014) · cites this paper as [7]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“No statistical methods were used to predetermine sample sizes but our sample sizes are similar to those reported in previous publications 7,16,44.”
From Tau promotes neurodegeneration through global chromatin relaxation (2014) · cites this paper as [7]
The cited source says what the claim attributes to it.
In the citing paper
“Studies in Drosophila indicate that cell cycle activation is causal for neuronal death in tauopathy, and that activation of the cell cycle in neurons is sufficient to induce neuronal death18.”
From Pathogenic tau-induced piRNA depletion promotes neuronal death through transposable element dysregulation in neurodegenerative tauopathies (2018) · cites this paper as [18]
The cited source says what the claim attributes to it.
In the citing paper
“Studies in Drosophila indicate that cell cycle activation is causal for neuronal death in tauopathy, and that activation of the cell cycle in neurons is sufficient to induce neuronal death18.”
From Pathogenic tau-induced piRNA depletion promotes neuronal death through transposable element dysregulation in neurodegenerative tauopathies (2018) · cites this paper as [18]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
Hutton, M., Lendon, C. L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., et al. (1998) · Nature · doi:10.1038/31508 · Cited by 3,498
Lee, V. M.-Y., Goedert, M., & Trojanowski, J. Q. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.1121 · Cited by 2,480
A Drosophila model of Parkinson's disease
Feany, M. Β., & Bender, W. W. (2000) · Nature · doi:10.1038/35006074 · Cited by 2,156
Self-citationThe tor pathway: a target for cancer therapy
Bjornsti, M., & Houghton, P. J. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1362 · Cited by 1,318
Regulation of lifespan in Drosophila by modulation of genes in the TOR signaling pathway
Kapahi, P., Zid, B. M., Harper, T., Koslover, D., Sapin, V., & Benzer, S. (2004) · Current Biology · doi:10.1016/j.cub.2004.03.059 · Cited by 1,293
Role and Regulation of Starvation-Induced Autophagy in the Drosophila Fat Body
Scott, R. C., Schuldiner, O., & Neufeld, T. P. (2004) · Developmental Cell · doi:10.1016/j.devcel.2004.07.009 · Cited by 979
Akt regulates growth by directly phosphorylating Tsc2
Potter, C. J., Pedraza, L. G., & Xu, T. (2002) · Nature Cell Biology · doi:10.1038/ncb840 · Cited by 959
Tauopathy in Drosophila : Neurodegeneration Without Neurofibrillary Tangles
Wittmann, C. W., Wszolek, M. F., Shulman, J. M., Salvaterra, P. M., Lewis, J., Hutton, M., & Feany, M. B. (2001) · Science · doi:10.1126/science.1062382 · Cited by 939
Self-citationA conditional tissue-specific transgene expression system using inducible GAL4
Osterwalder, T., Yoon, K. S., White, B. H., & Keshishian, H. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.221303298 · Cited by 804
Drosophila S6 kinase: a regulator of cell size.
Montagne, J., Stewart, M. J., Stocker, H., Hafen, E., Kozma, S., & Thomas, G. (1999) · Science · doi:10.1126/science.285.5436.2126 · Cited by 785
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 266
Rapamycin, proliferation and geroconversion to senescence
Blagosklonny, M. V. (2018) · Cell Cycle · doi:10.1080/15384101.2018.1554781 · Cited by 65
Wu, Y., Zhou, T., Wang, Q., Dai, P., Xu, S., Jia, H., & Wang, X. (2015) · Journal of Economic Entomology · doi:10.1093/jee/tov146 · Cited by 62
van Leeuwen, L. A. G., & Hoozemans, J. J. M. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1382-7 · Cited by 64
Drosophila Models of Tauopathies: What Have We Learned?
Gistelinck, M., Lambert, J., Callaerts, P., Dermaut, B., & Dourlen, P. (2012) · International Journal of Alzheimer s Disease · doi:10.1155/2012/970980 · Cited by 60
A neuroprotective role for the DNA damage checkpoint in tauopathy
Khurana, V., Merlo, P., DuBoff, B., Fulga, T. A., Sharp, K. A., Campbell, S. D., Götz, J., & Feany, M. Β. (2011) · Aging Cell · doi:10.1111/j.1474-9726.2011.00778.x · Cited by 58
Self-citationLee, H.-K., Kwon, B., Lemere, C. A., de la Monte, S., Itamura, K., Ha, A. Y., & Querfurth, H. W. (2017) · Journal of Alzheimer's Disease · doi:10.3233/jad-161029 · Cited by 57
Vereshchagina, N., Ramel, M., Bitoun, E., & WILSON, C. G. (2008) · Journal of Cell Science · doi:10.1242/jcs.035220 · Cited by 59
Jackson, W. S., Borkowski, A. W., Watson, N., King, O. D., Faas, H., Jasanoff, A., & Lindquist, S. L. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1312006110 · Cited by 53
Lrrk promotes tau neurotoxicity through dysregulation of actin and mitochondrial dynamics
Bardai, F. H., Ordonez, D. G., Bailey, R. M., Hamm, M. J., Lewis, J. M., & Feany, M. Β. (2018) · PLoS Biology · doi:10.1371/journal.pbio.2006265 · Cited by 55
Self-citationAlzheimer’s disease and related tauopathies: disorders of disrupted neuronal identity
Frost, B. E. (2023) · Trends in Neurosciences · doi:10.1016/j.tins.2023.07.006 · Cited by 57
Jahrling, J. B., & Laberge, R.-M. (2015) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026615666150610125856 · Cited by 55
Drosophila Models of Proteinopathies: the Little Fly that Could
Rincón-Limas, D. E., Jensen, K., & Fernández-Fúnez, P. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212799315894 · Cited by 51
Kou, X., Chen, D., & Chen, N. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20071591 · Cited by 52
Copani, A., Caraci, F., Hoozemans, J., Calafiore, M., Sortino, M., & Nicoletti, F. (2007) · Biochimica et Biophysica Acta · doi:10.1016/j.bbadis.2006.10.016 · Cited by 57
Drosophila comet assay: insights, uses, and future perspectives
Gaivão, I., & Sierra, L. M. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00304 · Cited by 48
Ma, Y., Wu, D., & LIU, J.-K. (2012) · Molecular Medicine Reports · doi:10.3892/mmr.2012.1186 · Cited by 49
Bolkan, B. J., & Kretzschmar, D. (2014) · Developmental Neurobiology · doi:10.1002/dneu.22199 · Cited by 47
Choi, C. H., Schoenfeld, B. P., Bell, A. J., Hinchey, J., Rosenfelt, C., Gertner, M. J., Campbell, S. R., Emerson, D., Hinchey, P., Kollaros, M., et al. (2016) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2016.00136 · Cited by 46
Important neuronal toxicity of microtubule-bound Tau in vivo in Drosophila
Talmat-Amar, Y., Arribat, Y., Redt‐Clouet, C., Feuillette, S., Bougé, A.-L., Lecourtois, M., & Parmentier, M. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr290 · Cited by 48
Developmental Expression of 4-Repeat-Tau Induces Neuronal Aneuploidy in Drosophila Tauopathy Models
Malmanche, N., Dourlen, P., Gistelinck, M., Demiautte, F., Link, N., Dupont, C., Broeck, L. V., Werkmeister, E., Amouyel, P., Bongiovanni, A., et al. (2017) · Scientific Reports · doi:10.1038/srep40764 · Cited by 48
Alzheimer's Disease and tauopathy studies in flies and worms
Wentzell, J. S., & Kretzschmar, D. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.03.007 · Cited by 46
Nanoparticles as a potential teratogen: a lesson learnt from fruit fly
Barik, B. K., & Mishra, M. (2018) · Nanotoxicology · doi:10.1080/17435390.2018.1530393 · Cited by 43
Implication of the transcription factor E2F-1 in the modulation of neuronal apoptosis
Verdaguer, E., Susana, G. D. A., Allgaier, C., Pallàs, M., & Camins, A. (2006) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2006.11.001 · Cited by 43
Unveiling the impact of aging on BBB and Alzheimer's disease: Factors and therapeutic implications
Jha, N. K., Jha, N. K., Nuli, M. V., Gupta, S. K., Kanna, S., Gahtani, R. M., Hani, U., Singh, A. K., Abomughaid, M. M., Abomughayedh, A. M., et al. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102224 · Cited by 43
Oshima, E., Ishihara, T., Yokota, O., Nakashima‐Yasuda, H., Nagao, S., Ikeda, C., Naohara, J., Terada, S., & Uchitomi, Y. (2013) · Brain Pathology · doi:10.1111/bpa.12059 · Cited by 44
Vascular mTOR-dependent mechanisms linking the control of aging to Alzheimer's disease
Galván, V., & Hart, M. J. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.11.010 · Cited by 41
Chatterjee, S., Ambegaokar, S. S., Jackson, G. R., & Mudher, A. K. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00801 · Cited by 40
Milošević, J., Schwarz, S. C., Ogunlade, V., Meyer, A. K., Storch, A., & Schwarz, J. (2009) · Molecular Neurodegeneration · doi:10.1186/1750-1326-4-25 · Cited by 38
Patrício, P., Mateus‐Pinheiro, A., Sousa, N., & Pinto, L. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8422-x · Cited by 39
Tau Mutations Serve as a Novel Risk Factor for Cancer
Rossi, G., Redaelli, V., Contiero, P., Fabiano, S., Tagliabue, G., Perego, P., Benussi, L., Bruni, A. C., Filippini, G., Farinotti, M., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-3175 · Cited by 38
Beharry, C., Alaniz, M. E., & Alonso, A. D. C. (2013) · Journal of Alzheimer's Disease · doi:10.3233/jad-130617 · Cited by 39
A Conserved Cytoskeletal Signaling Cascade Mediates Neurotoxicity of FTDP-17 Tau Mutations In Vivo
Bardai, F. H., Wang, L., Mutreja, Y., Yenjerla, M., Gamblin, T. C., & Feany, M. B. (2018) · The Journal of Neuroscience · doi:10.1523/jneurosci.1550-17.2017 · Cited by 37
Self-citationYang, T., Tran, K. C., Zeng, A. Y., Massa, S. M., & Longo, F. M. (2020) · Scientific Reports · doi:10.1038/s41598-020-77210-y · Cited by 40
Leugers, C. J., Koh, J. Y., Hong, W., & Lee, G. S. (2013) · Frontiers in Neurology · doi:10.3389/fneur.2013.00161 · Cited by 34
Soo, S. K., Rudich, P. D., Traa, A., Harris-Gauthier, N., Shields, H. J., & Raamsdonk, J. M. V. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111297 · Cited by 37
Lithium and the Interplay Between Telomeres and Mitochondria in Bipolar Disorder
Lundberg, M., Millischer, V., Backlund, L., Martinsson, L., Stenvinkel, P., Sellgren, C. M., Lavebratt, C., & Schalling, M. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.586083 · Cited by 38
Tau‐induced deficits in nonsense‐mediated mRNA decay contribute to neurodegeneration
Zuniga, G., Levy, S. A., Ramirez, P., Mange, J. D., Gonzalez, E. M., Gamez-Guijarro, M., & Frost, B. E. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12653 · Cited by 37
Hradek, A. C., Lee, H.-P., Siedlak, S. L., Torres, S. L., Jung, W., Han, A. H., & Lee, H.-G. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-141083 · Cited by 34
Povellato, G., Tuxworth, R. I., Hanger, D. P., & Tear, G. (2013) · Biology Open · doi:10.1242/bio.20136692 · Cited by 35
Papanikolopoulou, K., & Skoulakis, E. M. C. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddu726 · Cited by 33
Pathogenic Tau Causes a Toxic Depletion of Nuclear Calcium
Mahoney, R. E., Ochoa, E., Ramirez, P., Miller, H. E., Beckmann, A., Zuniga, G., Dobrowolski, R., & Frost, B. E. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107900 · Cited by 33
Study of tauopathies by comparing Drosophila and human tau in Drosophila
Chen, X., Li, Y., Huang, J., Cao, D., Yang, G., Liu, W., Lu, H., & Guo, A. (2007) · Cell and Tissue Research · doi:10.1007/s00441-007-0401-y · Cited by 35
Modeling Tauopathy in the Fruit Fly Drosophila melanogaster
Khurana, V. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-15403 · Cited by 31
Self-citationCaccamo, A., Belfiore, R., & Oddo, S. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.03.032 · Cited by 31
RetractedComparative proteomic analysis highlights metabolic dysfunction in α-synucleinopathy
Sarkar, S., Murphy, M. A., Dammer, E. B., Olsen, A. L., Rangaraju, S., Fraenkel, E., & Feany, M. Β. (2020) · npj Parkinson s Disease · doi:10.1038/s41531-020-00143-w · Cited by 30
Self-citationAn assessment of the translational relevance of Drosophila in drug discovery
Papanikolopoulou, K., Mudher, A. K., & Skoulakis, E. M. C. (2019) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2019.1569624 · Cited by 32
Abtahi, S., Masoudi, R., & Haddadi, M. (2020) · Gene · doi:10.1016/j.gene.2020.144854 · Cited by 31
Giong, H.-K., Subramanian, M., Yu, K., & Lee, J.-S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168465 · Cited by 31
Denéchaud, M., Geurs, S., Comptdaer, T., Bégard, S., García-Núñez, A., Pechereau, L.-A., Bouillet, T., Vermeiren, Y., Deyn, P. P. D., Perbet, R., et al. (2022) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2022.102386 · Cited by 29
Seidel, G., Meierhofer, D., Şen, N.-E., Guenther, A., Krobitsch, S., & Auburger, G. W. J. (2016) · Journal of Proteome Research · doi:10.1021/acs.jproteome.6b00647 · Cited by 30
An integrative systems-biology approach defines mechanisms of Alzheimer’s disease neurodegeneration
Leventhal, M. J., Zanella, C. A., Kang, B., Peng, J., Gritsch, D., Liao, Z., Bukhari, H., Wang, T., Pao, P., Danquah, S. A., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-59654-w · Cited by 35
Self-citationRyan, K. C., Ashkavand, Z., Sarasija, S., Laboy, J. T., Samarakoon, R., & Norman, K. R. (2021) · Aging Cell · doi:10.1111/acel.13472 · Cited by 27
Nuclear dynamics and stress responses in Alzheimer’s disease
Iatrou, A., Clark, E. M., & Wang, Y. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00489-6 · Cited by 31
NeuroGeM, a knowledgebase of genetic modifiers in neurodegenerative diseases
Na, D., Rouf, M., O’Kane, C. J., Rubinsztein, D. C., & Gsponer, J. A. (2013) · BMC Medical Genomics · doi:10.1186/1755-8794-6-52 · Cited by 27
Pharmacological Treatment of Alzheimer’s Disease: Insights from Drosophila melanogaster
Cheng, X., Song, C., Du, Y., Gaur, U., & Yang, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21134621 · Cited by 28
Liu, D., Ander, B. P., & Sharp, F. R. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.11.013 · Cited by 27
The Power and Richness of Modelling Tauopathies in Drosophila
Papanikolopoulou, K., & Skoulakis, E. M. C. (2011) · Molecular Neurobiology · doi:10.1007/s12035-011-8193-1 · Cited by 29
Aging and cancer: can mTOR inhibitors kill two birds with one drug?
Sharp, Z. D., & Richardson, A. G. (2011) · Targeted Oncology · doi:10.1007/s11523-011-0168-7 · Cited by 27
Studying tauopathies in Drosophila: A fruitful model
Sun, M., & Chen, L. (2015) · Experimental Neurology · doi:10.1016/j.expneurol.2015.03.029 · Cited by 27
Liu, D., & Ander, B. P. (2012) · The Scientific World JOURNAL · doi:10.1100/2012/491737 · Cited by 26
Aberrant E2F activation by polyglutamine expansion of androgen receptor in SBMA neurotoxicity
Suzuki, E., Zhao, Y., Ito, S., Sawatsubashi, S., Murata, T., Furutani, T., Shirode, Y., Yamagata, K., Tanabe, M., Kimura, S., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809819106 · Cited by 27
Beckmann, A., Ramirez, P., Gamez-Guijarro, M., Gonzalez, E. M., Mange, J. D., Bieniek, K. F., Ray, W. J., & Frost, B. E. (2023) · iScience · doi:10.1016/j.isci.2023.106152 · Cited by 24
Doğanlar, Z. B., Doğanlar, O., & Tabakçioğlu, K. (2014) · Water Air & Soil Pollution · doi:10.1007/s11270-014-2104-9 · Cited by 25
Animal Models of Alzheimer’s Disease
Newman, M., Kretzschmar, D., Khan, I., Chen, M., Verdile, G., & Lardelli, M. T. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809468-6.00040-1 · Cited by 25
Fanoudi, S., Hosseini, M., Alavi, M. S., Boroushaki, M. T., Hosseini, A., & Sadeghnia, H. R. (2018) · EXCLI journal · doi:10.17179/excli2018-1626 · Cited by 25
Liu, D., & Sharp, F. R. (2012) · Translational Stroke Research · doi:10.1007/s12975-012-0147-z · Cited by 25
Modelling Tauopathies in Drosophila : Insights from the Fruit Fly
Cowan, C. M., Sealey, M. A., Quraishe, S., Targett, M.-T., Marcellus, K. A., Allan, D. W., & Mudher, A. K. (2011) · International Journal of Alzheimer s Disease · doi:10.4061/2011/598157 · Cited by 26
Connecting cell-cycle activation to neurodegeneration in Drosophila
Khurana, V., & Feany, M. Β. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2006.10.007 · Cited by 24
Self-citationAn evaluation of Drosophila as a model system for studying tauopathies such as Alzheimer’s disease
Sivanantharajah, L., Mudher, A. K., & Shepherd, D. (2019) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2019.01.001 · Cited by 23
Shim, K.-H., Kim, S.-H., Hur, J., Kim, D., Demirev, A. V., & Yoon, S. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104519 · Cited by 23
Identification of cis-acting determinants mediating the unconventional secretion of tau
Katsinelos, T., McEwan, W. A., Jahn, T. R., & Nickel, W. (2021) · Scientific Reports · doi:10.1038/s41598-021-92433-3 · Cited by 16
Regulatory mechanism of cyclins and cyclin-dependent kinases in post-mitotic neuronal cell division
Gupta, R. V., Jha, A., Ambasta, R. K., & Kumar, P. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.120006 · Cited by 19
Amini, J., Sanchooli, N., Milajerdi, M.-H., Baeeri, M., Haddadi, M., & Sanadgol, N. (2023) · International Journal of Neuroscience · doi:10.1080/00207454.2023.2210409 · Cited by 19
Unraveling Alzheimer’s Disease Using Drosophila
Yeates, C. J., Sarkar, A., Kango‐Singh, M., & Singh, A. (2019) · Springer eBooks · doi:10.1007/978-981-13-2218-1_9 · Cited by 18
Cho, H.-J., Lee, W. S., Jeong, J., & Lee, J.-S. (2022) · Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology · doi:10.1016/j.cbpc.2022.109428 · Cited by 21
CDK1-FOXO1: A mitotic signal takes center stage in post-mitotic neurons
Kim, A. H., & Bonni, A. (2008) · Cell Cycle · doi:10.4161/cc.7.24.7215 · Cited by 17
Drosophila Orthologues to Human Disease Genes: An Update on Progress
Doronkin, S., & Reiter, L. T. (2008) · Progress in nucleic acid research and molecular biology · doi:10.1016/s0079-6603(08)00001-9 · Cited by 17
New Approaches to the Pathology and Genetics of Neurodegeneration
Feany, M. Β. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.091077 · Cited by 17
Self-citationZhang, X., Zhang, Y., Liu, S., Bulloj, A., Tong, G., Zhang, Z., Liao, F., & Xu, H. (2006) · Molecular Neurodegeneration · doi:10.1186/1750-1326-1-7 · Cited by 17
Murthy, M. N., & Shyamala, B. V. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.116897 · Cited by 16
Shukla, M., & Vincent, B. (2023) · Current Neuropharmacology · doi:10.2174/1570159x21666230314142505 · Cited by 17
Pathogenic tau induces an adaptive elevation in mRNA translation rate at early stages of disease
Zuniga, G., Katsumura, S., Mange, J. D., Ramirez, P., Atrian, F., Morita, M., & Frost, B. E. (2024) · Aging Cell · doi:10.1111/acel.14245 · Cited by 15
Targeting Gonadotropins: An Alternative Option for Alzheimer Disease Treatment
Casadesús, G., Puig, E. R., Webber, K. M., Atwood, C., Escuer, M. C., Bowen, R. L., Perry, G. L., & Smith, M. A. (2006) · BioMed Research International · doi:10.1155/jbb/2006/39508 · Cited by 15
Casali, C., Siciliani, S., Galgano, L., & Biggiogera, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010153 · Cited by 14
The Drosophila model system to study tau action
Trotter, M., Stephens, T. D., McGrath, J. P., & Steinhilb, M. L. (2017) · Methods in cell biology · doi:10.1016/bs.mcb.2017.06.006 · Cited by 15
Self-citationOligomerization of Lrrk controls actin severing and α-synuclein neurotoxicity in vivo
Sarkar, S., Bardai, F. H., Olsen, A. L., Lohr, K. M., Zhang, Y., & Feany, M. Β. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00454-3 · Cited by 13
Self-citationSchmidt, T., Wahl, P. R., Wuthrich, R. P., Vogetseder, A., Picard, N., Kaissling, B., & Hir, M. L. (2006) · Histochemistry and Cell Biology · doi:10.1007/s00418-006-0255-5 · Cited by 14
Mensah, L. B., Davison, C., Fan, S., Morris, J. F., Goberdhan, D. C. I., & WILSON, C. G. (2015) · PLoS ONE · doi:10.1371/journal.pone.0143818 · Cited by 13
Myre, M. A., Washicosky, K. J., Moir, R. D., Tesco, G., Tanzi, R. E., & Wasco, W. (2008) · Cellular Signalling · doi:10.1016/j.cellsig.2008.12.008 · Cited by 13
Hu, L., Mao, S., Li, L., Bai, G., Liu, B., & Mao, J. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105749 · Cited by 13
Microtubule disruption upon CNS damage triggers mitotic entry via TNF signaling activation
Barros, C. S., & Bossing, T. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109325 · Cited by 11
Tau Protein: Function and Pathology
Rosenmann, H., Blum, D. L., Kayed, R., & Ittner, L. M. (2012) · International Journal of Alzheimer s Disease · doi:10.1155/2012/707482 · Cited by 12
Therapeutic Targets in Alzheimer's Disease and Related Tauopathies
Corbo, C. P., & Alonso, A. D. C. (2011) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-385506-0.00002-8 · Cited by 13
Zhang, M. Y., Lear, B. C., & Allada, R. (2021) · Human Molecular Genetics · doi:10.1093/hmg/ddab303 · Cited by 11
Ma, Y., Wu, D., Zhang, W., Liu, J., Chen, S., & Hua, B. (2015) · PubMed Central · Cited by 11
Chiku, T., Motoki, H., Saito, T., Oka, M., Shinno, K., Ohtake, Y., Shimizu, S., Asada, A., Hisanaga, S., Iijima, K., et al. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.07.021 · Cited by 10
Liu, Y.-Z., Ma, L., Jiao, L.-B., Gao, M.-L., Guo, W.-Z., Chen, L., Pan, N., & Ma, Y.-Q. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.4444 · Cited by 11
Insights from Drosophila on Aβ- and tau-induced mitochondrial dysfunction: mechanisms and tools
Varte, V., Munkelwitz, J. W., & Rincón-Limas, D. E. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1184080 · Cited by 9
Unraveling the Basis of Neurodegeneration using the Drosophila Eye
Fernández-Fúnez, P., Sanchez-Garcia, J., & Rincón-Limas, D. E. (2013) · Springer eBooks · doi:10.1007/978-1-4614-8232-1_10 · Cited by 9
Loewen, C. A., Boekhoff‐Falk, G., Ganetzky, B., & Chtarbanova, S. (2018) · G3 Genes Genomes Genetics · doi:10.1534/g3.118.200627 · Cited by 9
Metadata
- Authors
- Khurana, V., Lu, Y., Steinhilb, M. L., Oldham, S., Shulman, J. M., & Feany, M. B.
- Affiliations
- Brigham and Women's Hospital (US)
- Sanford Burnham Prebys Medical Discovery Institute (US)
- Venue
- Current Biology
- Publisher
- Elsevier BV
- Published
- 2006-02
- Volume
- 16
- Issue
- 3
- Pages
- 230-241
- ISSN
- 0960-9822 (ISSN-L)
- OpenAlex
- W2064587868
- Cited by
- 266
- References
- 52
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 8 · 2023: 9 · 2022: 8 · 2021: 12 · 2020: 14 · 2019: 12 · 2018: 14 · 2017: 9 · 2016: 10 · 2015: 18 · 2014: 17 · 2013: 16 · 2012: 18
- FWCI
- 11.96
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Current Biology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (AG-19790, AG88001, R01AG019790)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurobiology and Insect Physiology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Keywords
- tauopathy, neurodegeneration, TOR signaling, cell cycle re-entry, postmitotic neurons, tau phosphorylation, apoptosis, Alzheimer's disease, Drosophila model, therapeutic target
- MeSH terms
- Animals, Cell Cycle, Drosophila, Enzyme Activation, Immunohistochemistry, Neurons, Protein Kinases, Blotting, Western, Signal Transduction, Apoptosis, Phosphatidylinositol 3-Kinases, In Situ Nick-End Labeling, Tauopathies, Drosophila Proteins, TOR Serine-Threonine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review